Can an immune booster before surgery beat lung cancer?
NCT ID NCT02994576
First seen Aug 17, 2026 · Last updated Aug 17, 2026
Summary
This trial is testing whether giving the immunotherapy drug atezolizumab before surgery can help people with early-stage non-small cell lung cancer. The study includes adults with stage IB to IIIA (non-N2) disease who are eligible for surgery. Participants receive one dose of atezolizumab, then undergo surgery, and the trial tracks safety and how well the treatment works.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- atezolizumab (an immunotherapy drug given by IV infusion before surgery)
- What this could lead to
- If it works, giving atezolizumab before surgery could shrink tumors and improve outcomes for people with early-stage lung cancer, potentially leading to a new treatment approach.
- What could go wrong
- This is a small, early-phase study, so results may not be conclusive. The drug can cause immune-related side effects, and surgery delays or complications are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NONSMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Hospitalier de Chauny
Chauny, France
-
Centre Marie Lannelongue
Le Plessis-Robinson, France
-
Gustave Roussy
Villejuif, Val de Marne, 94805, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- First-in-Class cancer drug targets Hard-to-Treat tumors
- Experimental combo for lung cancer shows promise but study cut short
- AI takes on lung cancer: can a computer match a Doctor's wisdom?
- Can we treat sicker lung cancer patients the same as healthier ones?
- Electric field therapy extends life in advanced lung cancer trial
- New immunotherapy shows promise against lung cancer in major trial